To determine whether iCD8α+ NK cells retained their enhanced functionality over longer time periods, we injected sorted CD8α+ and CD8α– CD56dim NK cells into NSG mice, infused them with K562 tumor cells the following day, and supported this with i.p. injections of IL-15 (Figure 8D). This evidence concerns the gene CD8A and neoplasm.